NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel cancer therapeutics, today announced that the Company is scheduled to present at the Bear Stearns 2007 SMid-Cap Conference in New York, NY on Wednesday, November 14, 2007 at 10:00 a.m. EST. A corporate overview will be provided, including additional information on the Company’s product portfolio.
The presentation will be webcast live and may be accessed by visiting ImClone Systems’ website at www.imclone.com. A replay of the webcast will also be available following the presentation. Investors can access the webcast under “Presentations” in the “Investor Relations” section of ImClone Systems’ website.
